Skip to content

:

Articles related to focusing on healthy aging, prevention, mobility, cognition, nutrition, independence, and caregiving support.

5 min

How safe is romosozumab? Evaluating risks, side effects, and patient considerations

Romosozumab (brand name Evenity) is a potent osteoporosis medication designed to reduce fracture risk by both building new bone and decreasing bone breakdown. A key part of managing this therapy involves understanding **how safe is romosozumab** and what precautions are necessary, particularly regarding a boxed warning for cardiovascular events.

Read Healthy Aging
5 min

Do all osteoporosis drugs cause osteonecrosis? A look at medication risks

According to the American College of Rheumatology, the risk of osteonecrosis of the jaw (ONJ) for osteoporosis patients taking oral bisphosphonates is less than 0.1%. It is a common misconception that all osteoporosis drugs cause osteonecrosis, but the risk is predominantly associated with specific antiresorptive medications, particularly at higher doses and with longer-term use. This article clarifies the actual risk and provides insight into which patients are most susceptible.

Read Healthy Aging